Yuntao Wu
- Virology top 0.5%
- HIV Research and Treatment 48
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment 13
- SARS-CoV-2 and COVID-19 Research 5
- COVID-19 Clinical Research Studies 4
- Immunology top 2%
- Immune Cell Function and Interaction 26
- T-cell and B-cell Immunology 13
- Neurology top 5%
- Molecular Biology top 10%
-
- Cytomegalovirus and herpesvirus research 10
-
- Virus-based gene therapy research 5
- Partner nations
- United StatesChinaCanada
In The Last Decade
Yuntao Wu
62 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Virology 1.6k
- Infectious Diseases 1.3k
- Immunology 1.0k
- Neurology 243
- Molecular Biology 1.0k
Countries citing papers authored by Yuntao Wu
This map shows the geographic impact of Yuntao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuntao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuntao Wu more than expected).
Fields of papers citing papers by Yuntao Wu
This network shows the impact of papers produced by Yuntao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuntao Wu. The network helps show where Yuntao Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuntao Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2022 | 7 | |
| 5 | 2021 | 1 | |
| 6 | 2020 | 18 | |
| 7 | 2020 | 18 | |
| 8 | 2020 | 16 | |
| 9 | 2019 | 14 | |
| 10 | 2019 | 25 | |
| 11 | 2018 | 14 | |
| 12 | 2017 | 61 | |
| 13 | 2015 | 25 | |
| 14 | 2013 | 24 | |
| 15 | 2009 | 112 | |
| 16 | 2009 | 69 | |
| 17 | 2008 | 37 | |
| 18 | 2008 | 232 | |
| 19 | 2007 | 72 | |
| 20 | 2003 | 28 |
About Yuntao Wu
Yuntao Wu is a scholar working on Virology, Immunology and Infectious Diseases, having authored 67 papers that have together received 3.3k indexed citations. Recurring topics across this work include HIV Research and Treatment (48 papers), Immune Cell Function and Interaction (26 papers), HIV/AIDS drug development and treatment (13 papers), T-cell and B-cell Immunology (13 papers), Cytomegalovirus and herpesvirus research (10 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Virus-based gene therapy research (5 papers) and COVID-19 Clinical Research Studies (4 papers). The work is most often cited by research in Virology (1.6k citations), Infectious Diseases (1.3k citations) and Immunology (1.0k citations). Yuntao Wu has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Jon W. Marsh, Yajing Fu, Yuanxiong Cheng, Alyson Yoder, Jia Guo, Weifeng Wang, Dongyang Yu, Mark Spear, Zichong Li and Qiang Zhou.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.